Kaiser Gypsum Company: Asbestos-Containing Joint Compound and Finishing Products

Kaiser Gypsum Company manufactured asbestos-containing joint compounds and finishing products that were used extensively in residential and commercial construction across the United States from the early 1950s through the mid-1970s. Workers who handled Kaiser joint compound during drywall installation, taping, and finishing operations faced repeated exposure to airborne asbestos fibers. Kaiser Gypsum filed for Chapter 11 bankruptcy protection in 2016 specifically to address the volume of asbestos personal injury claims arising from its products, and the Kaiser Gypsum Company Asbestos PI Trust was subsequently established to compensate eligible claimants.

Company History

Kaiser Gypsum Company was founded in 1952 in Oakland, California, as part of the broader Kaiser industrial network established by Henry J. Kaiser. The company entered the building materials market during a period of explosive postwar residential and commercial construction, positioning its gypsum-based products for wide distribution to contractors and builders nationwide.

Throughout the 1950s, 1960s, and into the 1970s, Kaiser Gypsum competed in the joint compound and finishing products market alongside other major manufacturers. Asbestos was incorporated into joint compound formulations during this era because it improved product workability, reduced cracking during drying, and added tensile strength to finished seams. These properties made asbestos-containing joint compounds commercially attractive and technically advantageous by the standards of the time.

Kaiser Gypsum ceased using asbestos in its product formulations by 1977, following increased regulatory attention to asbestos hazards in building materials and growing scientific understanding of asbestos-related disease. However, products manufactured before that cutoff date had already been distributed and installed across millions of square feet of American residential and commercial construction.

Decades later, the cumulative weight of asbestos personal injury litigation compelled the company to seek bankruptcy protection. Kaiser Gypsum Company filed for Chapter 11 in 2016, with the explicit purpose of creating a structured resolution mechanism for asbestos claims. The reorganization process led to the establishment of the Kaiser Gypsum Company Asbestos PI Trust, which remains active and accepts claims from individuals diagnosed with asbestos-related diseases attributable to exposure to Kaiser Gypsum products.

Asbestos-Containing Products

Kaiser Gypsum manufactured asbestos-containing products in two primary categories relevant to drywall and finishing trades:

Kaiser Joint Compound

Kaiser joint compound, in its asbestos-containing formulation, was produced and sold from the 1950s through the mid-1970s. This product was applied by drywall finishers, tapers, and general construction workers to fill seams between gypsum wallboard panels, cover fasteners, and create smooth interior wall surfaces. The asbestos content in joint compound formulations of this era was typically incorporated as chrysotile fiber, though product composition varied by formulation and production year.

The exposure hazard associated with Kaiser joint compound arose primarily from mixing and application activities. Dry joint compound powder, when mixed with water, released asbestos fibers into the air. Sanding dried compound — a routine step in achieving smooth wall finishes — generated fine dust containing respirable asbestos fibers that could remain airborne for extended periods in enclosed spaces.

Kaiser Texture and Finishing Products

Kaiser Gypsum also manufactured texture and finishing products used to create decorative surface treatments on walls and ceilings. These products, applied by brush, roller, or spray equipment, similarly contained asbestos in formulations produced during the relevant period. Spray application of texture compounds was a particular concern, as the application method generated a fine mist capable of distributing asbestos fibers throughout a work area.

Both product lines were distributed through building supply channels and reached jobsites across the country, appearing in new home construction, apartment buildings, schools, offices, and commercial interiors built or renovated during the peak usage period.

Occupational Exposure

Workers in the drywall and finishing trades faced the most direct and sustained exposure to Kaiser Gypsum’s asbestos-containing products. The following occupations are commonly associated with documented exposure histories involving Kaiser joint compound and finishing materials:

  • Drywall finishers and tapers, who mixed, applied, and sanded joint compound as a core job function, often working in enclosed spaces with limited ventilation
  • Plasterers and interior finish workers, who applied texture and finishing coats to walls and ceilings
  • Carpenters and general construction laborers, who worked in proximity to finishing operations on residential and commercial jobsites
  • Painters and decorators, who frequently sanded and prepared compound-finished surfaces before applying paint
  • Demolition and renovation workers, who disturbed existing compound-finished drywall in older structures, releasing previously fixed asbestos fibers
  • Insulation workers and other trades, who shared work areas with drywall finishing operations

Secondary exposure is also documented. Family members of workers who handled Kaiser joint compound may have been exposed to asbestos fibers carried home on work clothing, skin, and hair. This bystander exposure pathway has been recognized in asbestos personal injury claims and is considered relevant to trust eligibility determinations.

Exposure risk was not limited to professional tradespeople. Homeowners who undertook do-it-yourself drywall repair and finishing projects using Kaiser products during the relevant decades may also have incurred meaningful asbestos exposure, particularly if they sanded dried compound in enclosed rooms without respiratory protection.

The diseases most commonly associated with occupational asbestos exposure include mesothelioma, lung cancer, asbestosis, and other asbestos-related pleural conditions. These diseases characteristically have long latency periods — often 20 to 50 years between initial exposure and clinical diagnosis — meaning that workers exposed to Kaiser Gypsum products in the 1960s and 1970s may be receiving diagnoses today.

Chapter 11 Filing and Trust Establishment

Kaiser Gypsum Company filed for Chapter 11 bankruptcy protection in 2016 in response to the ongoing volume of asbestos personal injury litigation stemming from its joint compound and finishing products. The bankruptcy reorganization was structured specifically to address these liabilities, and the Kaiser Gypsum Company Asbestos PI Trust was created as the mechanism through which valid claims are compensated.

The trust operates under a Trust Distribution Procedures (TDP) document that governs claim eligibility, required evidence, disease categories, and payment levels. Claimants do not need to pursue litigation to receive compensation through the trust; the trust is designed to allow eligible individuals to submit claims directly and receive payment according to the established procedures.

Who May Be Eligible to File

Individuals who may be eligible to file a claim with the Kaiser Gypsum Company Asbestos PI Trust include:

  • Workers who can document occupational exposure to Kaiser joint compound or Kaiser texture and finishing products during the period of asbestos-containing formulation use (approximately 1952–1977)
  • Workers who were present in areas where Kaiser products were mixed, applied, or sanded, even if they did not directly handle the product themselves
  • Family members who experienced secondary exposure through contact with workers who handled Kaiser products
  • The estates of deceased individuals who would otherwise have been eligible, submitted by surviving family members or legal representatives

Evidence Supporting a Claim

Trust claims are evaluated based on documentation of both product exposure and an asbestos-related diagnosis. Useful evidence typically includes employment records, union membership documentation, Social Security work history, affidavits from former coworkers or supervisors, contractor and jobsite records, and medical records confirming an eligible asbestos-related disease. Attorneys who specialize in asbestos trust claims can assist in gathering and presenting this documentation effectively.

Consulting an Attorney

Because trust claim procedures involve specific filing requirements, disease classification criteria, and documentation standards, most claimants work with an attorney experienced in asbestos litigation and trust fund claims. Attorneys who handle these matters typically work on a contingency basis, meaning no upfront legal fees are charged. Consulting with an asbestos attorney does not obligate you to file a claim but can help you understand whether your exposure history and diagnosis qualify under the Kaiser Gypsum Trust’s distribution procedures.

Summary

Kaiser Gypsum Company manufactured asbestos-containing joint compound and finishing products from 1952 until 1977. These products were widely used in American residential and commercial construction, and workers in drywall finishing, plastering, carpentry, and related trades faced repeated exposure to airborne asbestos fibers during mixing, application, and sanding operations. Kaiser Gypsum filed for Chapter 11 bankruptcy in 2016 specifically to resolve asbestos personal injury liabilities, and the Kaiser Gypsum Company Asbestos PI Trust is currently active and accepting claims. If you or a family member have been diagnosed with mesothelioma, lung cancer, asbestosis, or another asbestos-related disease and have a history of exposure to Kaiser joint compound or Kaiser finishing products, you may be eligible to file a claim with the trust. An attorney experienced in asbestos trust fund claims can evaluate your exposure history and diagnosis and guide you through the filing process.